...
机译:曲妥珠单抗治疗的Her2阳性乳腺癌中PI3KCA突变和/或PTEN丢失与抗Her2治疗的耐药性无关
Unit of Surgical Pathology Laboratory of Molecular Pathology Trentino Biobank S. Chiara Hospital Trento Italy;
Unit of Surgical Pathology Laboratory of Molecular Pathology Trentino Biobank S. Chiara Hospital Trento Italy;
Unit of Surgical Pathology Laboratory of Molecular Pathology Trentino Biobank S. Chiara Hospital Trento Italy;
Unit of Surgical Pathology Laboratory of Molecular Pathology Trentino Biobank S. Chiara Hospital Trento Italy;
Bruno Kessler Foundation Trento Italy;
Unit of Surgical Pathology Laboratory of Molecular Pathology Trentino Biobank S. Chiara Hospital Trento Italy;
Unit of Medical Oncolgy S. Chiara Hospital Trento Italy;
Unit of Medical Oncolgy S. Chiara Hospital Trento Italy;
Unit of Medical Oncolgy S. Chiara Hospital Trento Italy;
Unit of Surgical Pathology Laboratory of Molecular Pathology Trentino Biobank S. Chiara Hospital Trento Italy;
Unit of Surgical Pathology Laboratory of Molecular Pathology Trentino Biobank S. Chiara Hospital Trento Italy;
Unit of Medical Oncolgy S. Chiara Hospital Trento Italy;
Unit of Surgical Pathology Laboratory of Molecular Pathology Trentino Biobank S. Chiara Hospital Trento Italy;
Breast cancer; Her2; Trastuzumab; PI3KCA mutation; PTEN loss;
机译:曲妥珠单抗治疗的Her2阳性乳腺癌中PI3KCA突变和/或PTEN丢失与抗Her2治疗的耐药性无关
机译:辅助化疗和曲妥珠单抗治疗的HER2阳性早期乳腺癌患者中PIK3CA突变,PTEN和pHER2表达及其对预后的影响
机译:辅助化疗和曲妥珠单抗治疗的HER2阳性早期乳腺癌患者PIK3CA突变,PTEN和pHER2表达及其对预后的影响
机译:HER2阳性乳腺癌中的WBP2表达升高与基于曲妥珠单抗的新辅助治疗的敏感性相关:回顾性和多中心研究
机译:肠道微生物群和胸瘤反应在Her2阳性乳腺癌中
机译:HER2阳性转移性乳腺癌中PTEN丢失和PIK3CA突变的评估及其与曲妥珠单抗治疗的相关性:一项回顾性研究(KBC-SG 1001)
机译:PIK3CA突变和PTEN缺失与曲妥珠单抗治疗转移性乳腺癌疗效的关系评估